Clik here to view.
EU pushing for data exclusivity in Thai-EU FTA
Data exclusivity a life and death issue Source: Bangkok Post During the last week of July, a team from the Department of Trade Negotiation (DTN) went to Brussels to work on a scoping exercise with the...
View ArticleClik here to view.
EU-India Free Trade Negotiations Threatening Access to Medicines
Posted on IP Health, 28-9-12 By Kajal Bhardwaj and Hans Löfgren Indian firms are major global producers of relatively affordable generic medicines. Access to such drugs make the difference between...
View ArticleClik here to view.
Dept probes drug access fears
Source: Bangkok Post 3 Oct 2012 The Trade Negotiations Department has agreed to compare the texts of the proposed Thailand-EU Free Trade Agreement with those of other countries after concerns raised by...
View ArticleClik here to view.
Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents...
Source: IP Health Authors: Tahir Amin and Aaron Kesselheim Pharmaceutical manufacturers rely on patents to protect their intellectual property and often seek to extend market exclusivity for their...
View ArticleClik here to view.
Tables on data exclusivity and patent linkage provisions in TPP and US FTAs
New tables by Public Citizen’s on Patent Linkage and data exclusivity provisions in U.S. FTAs with ——and the U.S. proposal to the TPP: Comparative Table of Patent Linkage Provisions in U.S. FTAs and...
View ArticleClik here to view.
Free Trade Agreement between the European Union & India threatens access to...
CASABLANCA, April 9th 2013 – For immediate release • GLOBAL WEEK OF ACTION ON EU FTAS: 9-15TH APRIL 2013 Source: ITPC Mena The International Treatment Preparedness Coalition in North Africa and the...
View ArticleClik here to view.
Trade deal jeopardizes generics production
Source: Deutsche Welle 25th April,2013 As a free trade agreement between the European Union and India reaches the final stages, activists are worried it could stifle India’s ability to supply...
View ArticleClik here to view.
US Special 301 report 2013: India on priority watch list again
Excerpts from the report on India: India remains on the Priority Watch List in 2013. In 2012, India made limited progress in improving its weak IPR legal framework and enforcement system. Comments on...
View ArticleClik here to view.
Senators Back 12-Year Data Exclusivity Period for Biosimilars and President...
Source: Patent Docs On March 22, Senators Max Baucus (D-MT) and Orrin Hatch (R-UT), the Chairman and Ranking Member, respectively, of the Senate Committee on Finance, sent a letter to Ambassador...
View ArticleClik here to view.
Trans Pacific Partnership Negotiations and the Controversial Issue of...
Source: Infojustice May 17,2013 Trade negotiators are meeting in Lima, Peru this week for the seventeenth round of talks on the proposed Trans Pacific Partnership (TPP). The negotiations are reaching...
View ArticleClik here to view.
Activists Warn Trade Pact Will Keep out Generics
By EILEEN NG Associated Press KUALA LUMPUR, Malaysia July 3, 2013 (AP) A free trade pact being negotiated by the U.S. and 11 Asia-Pacific nations will impose aggressive intellectual property rules that...
View ArticleClik here to view.
Merck and Roche killing Hep-C patients
Here is a site, devoted to the greed of the pharmaceutical companies Roche and Merck: http://merckrochenomercy.re/en.php Their prices are killing people with hepatitis C!
View ArticleClik here to view.
How drug companies price patients out of survival
Source: Salon As our television screens toggle between pundits squabbling over Obamacare’s insurance rules and ads for erectile dysfunction remedies, another health care battle rages in village clinics...
View ArticleClik here to view.
Differential Treatment and Developing Country Transition Periods in the IP...
Source: Infojustice Inside U.S. Trade (Nov. 27, 2013) has reported that the U.S. floated a non-paper proposal for differential treatment and a transition period for developing country partners...
View ArticleClik here to view.
Campaign for Affordable Trastuzumab responds to Delhi High Court Order on...
As per the Delhi High Court order delivered on February 5, 2014, Roche has pressed for an ex-parte ad-interim order restraining Biocon and Mylan from launching, introducing, selling and marketing...
View ArticleClik here to view.
Swiss-Indian trade deal: bitter pill to swallow
Source: SWI 25 Feb 2014 Indian Minister of Commerce and Industry Anand Sharma (right) speaks to Francis Gurry, director general of the World Intellectual Property Organization in Geneva (Keystone) Who...
View ArticleClik here to view.
A matter of life and death
Source: Kashmir Times 11 April 2014 If you or some family members or friends suffer from cancer, hepatitis, AIDs, asthma or other serious ailments, it’s worth your while to follow the Trans-Pacific...
View ArticleClik here to view.
Low Expectations For Hanoi Round Cast Doubt On November TPP Result
Source: World Trade Online 3 Sep 2014 At an informal round of talks taking place Sept. 1-10 in Hanoi, Trans-Pacific Partnership (TPP) negotiators are poised to confront some of the most contentious...
View ArticleClik here to view.
Ecuador Takes One Step Forward for Health (Issues New Compulsory Licenses)...
Source: Citizen 4 Sep 2014 In July, Ecuador issued four compulsory licenses for medicines targeting cancer and arthritis treatment and immunological reception to kidney transplant.1 These licenses...
View ArticleClik here to view.
FDA Changes Policy Hours Before Approvals, Giving Companies Gift Potentially...
Source: Posted 13 October 2014 By Alexander Gaffney, RAC Source: The Regulatory Affairs Professionals Society (RAPS) On Friday, two companies were the lucky recipients of gifts never before given by...
View Article